Mycophenolate mofetil immunosuppression in high-risk renal transplant recipients

By Abouna G.M.   Al Arrayed A.S.   Farid E.   Awad C.K.   Sharqawi S.A.-D.   Tantawi M.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4077-4078

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients

By Esmeraldo R.M.   Donadi M.O.R.C.   Oliveira M.L.   Ponte C.N.   Pinheiro P.M.A.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 3007-3008

Elsevier

Access to resources Recommend Favorite

Pharmacoeconomic analysis of preemptive gancyclovir therapy in the prevention of cytomegalovirus infections in high-risk renal graft recipients

By Chak W.L.   Choi K.S.   Wong K.M.   Chan Y.H.   Chau K.F.   Li C.S.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 280-281

Elsevier

Access to resources Recommend Favorite

Augmentation of Mycophenolate Mofetil Pharmacokinetics in Renal Transplant Patients Receiving Prograf and Cellcept in Combination Therapy

By Zucker K.   Rosen A.   Tsaroucha A.   de Faria L.   Roth D.   Ciancio G.   Esquenazi V.   Burke G.   Tzakis A.   Miller J.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 334-336

Elsevier

Access to resources Recommend Favorite

Zenapax versus OKT-3 prophylaxis in immunologically high-risk kidney transplant recipients

By Lacha J.   Smova M.   Noskova L.   Teplan V.   Vtko S.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2273-2274

Elsevier

Access to resources Recommend Favorite